These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 27369864

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Bioactivities of ricin retained and its immunoreactivity to anti-ricin polyclonal antibodies alleviated through pegylation.
    Hu RG, Zhai QW, He WJ, Mei L, Liu WY.
    Int J Biochem Cell Biol; 2002 Apr; 34(4):396-402. PubMed ID: 11854038
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.
    Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H.
    Drug Discov Today; 2014 Dec; 19(12):1945-52. PubMed ID: 25205349
    [Abstract] [Full Text] [Related]

  • 26. Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.
    Ozer I, Kelly G, Gu R, Li X, Zakharov N, Sirohi P, Nair SK, Collier JH, Hershfield MS, Hucknall AM, Chilkoti A.
    Adv Sci (Weinh); 2022 Apr; 9(11):e2103672. PubMed ID: 35133079
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. PEGylation and its impact on the design of new protein-based medicines.
    Ginn C, Khalili H, Lever R, Brocchini S.
    Future Med Chem; 2014 Apr; 6(16):1829-46. PubMed ID: 25407370
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice.
    McSweeney MD, Shen L, DeWalle AC, Joiner JB, Ciociola EC, Raghuwanshi D, Macauley MS, Lai SK.
    J Control Release; 2021 Jan 10; 329():774-781. PubMed ID: 33038448
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A, Xiong CY, Albrecht H, DeNardo GL, DeNardo SJ.
    Bioconjug Chem; 2005 Jan 10; 16(1):113-21. PubMed ID: 15656582
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chemistry for peptide and protein PEGylation.
    Roberts MJ, Bentley MD, Harris JM.
    Adv Drug Deliv Rev; 2002 Jun 17; 54(4):459-76. PubMed ID: 12052709
    [Abstract] [Full Text] [Related]

  • 38. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T.
    Mol Pharm; 2015 Jul 06; 12(7):2429-35. PubMed ID: 26070445
    [Abstract] [Full Text] [Related]

  • 39. Discussion about several potential drawbacks of PEGylated therapeutic proteins.
    Zhang F, Liu MR, Wan HT.
    Biol Pharm Bull; 2014 Jul 06; 37(3):335-9. PubMed ID: 24334536
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.